Clinical Trial Update: Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamic study on AZD1722 in end-stage renal disease patients on hemodialysis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• End-stage Renal Disease

Drugs mentioned

• AZD1722

Snippet

Sponsor: Ardelyx | Conditions: End Stage Renal Disease, Chronic Kidney Disease Stage 5 | Phase 2 | Status: COMPLETED | Results posted: 2020-08-10